Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Diagnostic Pathology
Published in: Diagnostic Pathology 1/2015

Open Access 01-12-2015 | Research

Evaluation of the correlation of KAI1/CD82, CD44, MMP7 and β-catenin in the prediction of prognosis and metastasis in colorectal carcinoma

Authors: Qiong Wu, Yan Yang, Shiwu Wu, Wanyun Li, Na Zhang, Xiuqin Dong, Yurong Ou

Published in: Diagnostic Pathology | Issue 1/2015

Login to get access

Abstract

Background

To investigate the relationship of KAI1/CD82, CD44, matrix metalloproteinase 7 (MMP7) and β-catenin, and examine its association with clinicopathological features, metastasis and prognosis in colorectal carcinoma (CRC).

Methods

Immunohistochemical (IHC) analysis was used to detect the expression of KAI1/CD82, CD44, MMP7 and β-catenin in 174 archival surgical specimens of human CRC. Furthermore, clinicopathological features such as age, sex and so on were also collected retrospectively.

Results

CD44, MMP7 and β-catenin expression was positively associated with distant metastasis, lymph node metastasis and tumor-node-metastasis (TNM) stage. However, decreased KAI1/CD82 expression correlated significantly with distant metastasis, lymph node metastasis and TNM stage. KAI1/CD82 expression showed a negative correlation with CD44, MMP7 and β-catenin. Furthermore, β-catenin expression showed a positive correlation with CD44 and MMP7. Multivariate logistic regression analysis showed that KAI1/CD82 and β-catenin expression were significantly associated with lymph node metastasis and KAI1/CD82 was significantly associated with distant metastasis. Kaplan-Meier analysis revealed that CD44, MMP7 and β-catenin expression was negatively correlated with overall survival (OS), while KAI1/CD82 expression was positively correlated with OS. Low KAI1/CD82 expression and high expression of CD44, MMP7 and β-catenin was associated with a poor prognosis in CRC. Multivariate Cox regression analysis indicated that the expression of KAI1/CD82, MMP7 and β-catenin were independent predictors of OS in CRC.

Conclusion

The expression of KAI1/CD82, CD44, MMP7 and β-catenin is related to tumor metastasis and prognosis in CRC. Combined detection of these factors may be of significant value in predicting the prognosis and metastasis in CRC patients.
Literature
1.
Zhang SC, Jin W, Liu H, Jin MJ, Chen ZX, Ding ZY, et al. Annual report on status of cancer in China, 2010. Chin J Cancer Res. 2014;26:48–58.PubMedCentralPubMed
2.
3.
Siegel R, DeSantis C, Jemal A. Colorectal Cancer Statistics, 2014. CA Cancer J Clin. 2014;64:104–17.CrossRefPubMed
4.
Mina LA, Sledge Jr GW. Rethinking the metastatic cascade as a therapeutic target. Nat Rev Clin Oncol. 2011;8:325–32.PubMed
5.
Huh JW, Kim HR, Kim YJ, Lee JH, Park YS, Cho SH, et al. Expression of standard CD44 in human colorectal carcinoma: Association with prognosis. Pathol Int. 2009;59:241–6.CrossRefPubMed
6.
Bienstock RJ, Barrett JC. KAI1, a prostate metastasis suppressor: prediction of solvated structure and interactions with binding partners; integrins, cadherins and cell-surface receptor proteins. Mol Carcinog. 2001;32:139–53.
7.
Dong JT, Lamb PW, Rinker-Schaeffer CW, Vukanovic J, Ichikawa T, Isaacs JT, et al. KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science. 1995;268:884–6.CrossRefPubMed
8.
Malik FA, Sanders AJ, Jiang WG. KAI-1/CD82, The molecule and clinical implication in cancer and cancer metastasis. Histol Histopathol. 2009;24:519–30.PubMed
9.
Naor D, Sionov RV, Ish-Shalom D. CD44: structure, function, and association with the malignant process. Adv Cancer Res. 1997;71:241–319.CrossRefPubMed
10.
Ponta H, Sherman L, Herrlich PA. CD44: from adhesion molecules to signalling regulators. Nat Rev Mol Cell Biol. 2003;4:33–45.CrossRefPubMed
11.
Kim HR, Wheeler MA, Wilson CM, Iida J, Eng D, Simpson MA, et al. Hyaluronan facilitates invasion of colon carcinoma cells in vitro via interaction with CD44. Cancer Res. 2004;64:4569–76.CrossRefPubMed
12.
Ii M, Yamamoto H, Adachi Y, Maruyama Y, Shinomura Y. Role of Matrix Metalloproteinase-7 (Matrilysin) in Human Cancer Invasion, Apoptosis, Growth, and Angiogenesis. Exp Biol Med (Maywood). 2006;231:20–7.
13.
Curran S, Murray GI. Matrix metalloproteinases in tumour invasion and metastasis. J Pathol. 1999;189:300–8.CrossRefPubMed
14.
Aberle H, Schwartz H, Kemler R. Cadherin-catenin complex: protein interactions and their implications for cadherin function. J Cell Biochem. 1996;61:514–23.CrossRefPubMed
15.
Behrens J, von Kries JP, Kühl M, Bruhn L, Wedlich D, Grosschedl R, et al. Functional interaction of beta-catenin with the transcription factor LEF-1. Nature. 1996;382:638–42.CrossRefPubMed
16.
Yang Y, Yang JJ, Tao H, Jin WS. New perspectives on β-catenin control of cell fate and proliferation in colon cancer. Food Chem Toxicol. 2014;74:14–9.CrossRefPubMed
17.
Chen Z, He X, Jia M, Liu Y, Qu D, Wu D, et al. β-catenin overexpression in the nucleus predicts progress disease and unfavourable survival in colorectal cancer: a meta-analysis. PLoS One. 2013;8:e63854.
18.
Maruyama K, Ochiai A, Akimoto S, Nakamura S, Baba S, Moriya Y, et al. Cytoplasmic beta-catenin accumulation as a predictor of hematogenous metastasis in human colorectal cancer. Oncology. 2000;59:302–9.CrossRefPubMed
19.
Gao ZH, Lu C, Wang MX, Han Y, Guo LJ, et al. Differential β-catenin expression levels are associated with morphological features and prognosis of colorectal cancer. Oncol Lett. 2014;8:2069–76.PubMedCentralPubMed
20.
Muneyuki T, Watanabe M, Yamanaka M, Shiraishi T, Isaji S. KAI1/CD82 Expression as a prognosic factor in sporadic colorectal cancer. Anticancer Res. 2001;21:3581–7.PubMed
21.
Adachi Y, Yamamoto H, Itoh F, Hinoda Y, Okada Y, Imai K. Contribution of matrilysin (MMP-7) to the metastatic pathway of human colorectal cancers. Gut. 1999;45:252–8.PubMedCentralCrossRefPubMed
22.
Lombardi DP, Geradts J, Foley JF, Chiao C, Lamb PW, Barrett JC. Loss of KAI1 expression in the progression of colorectal cancer. Cancer Res. 1999;59:5724–31.PubMed
23.
Maurer CA, Graber HU, Friess H, Beyermann B, Willi D, Netzer P, et al. Reduced expression of the metastasis suppressor gene KAI1 in advanced colon cancer and its metastases. Surgery. 1999;126:869–80.CrossRefPubMed
24.
Hashida H, Takabayashi A, Tokuhara T, Hattori N, Taki T, Hasegawa H. Clinical significance of transmembrane 4 superfamily in colon cancer. Br J Cancer. 2003;89:158–67.PubMedCentralCrossRefPubMed
25.
Yang JL, Jackson P, Yu Y, Russell PJ, Markovic B, Crowe PJ. Expression of the KAI1 metastasis suppressor gene in non-metastatic versus metastatic human colorectal cancer. Anticancer Res. 2002;22:3337–42.PubMed
26.
Al-Maghrabi J, Gomaa W, Buhmeida A, Al-Qahtani M, Al-Ahwal M. Decreased immunoexpression of standard form of CD44 is an independent favourable predictor of nodal metastasis in colorectal carcinoma. Anticancer Res. 2012;32(8):3455–61.PubMed
27.
Khoursheed M, Mathew TC, Makar RR, Sonia L, Abul H, Asfar S, et al. Expression of CD44s in human colorectal cancer. Pathol Oncol Res. 2002;8:170–4.CrossRefPubMed
28.
Ropponen KM, Eskelinen MJ, Lipponen PK, Alhava E, Kosma VM. Expression of CD44 and Variant Proteins in Human Colorectal Cancer and Its Relevance for Prognosis. Scand J Gastroenterol. 1998;33:301–9.CrossRefPubMed
29.
Brabletz T, Jung A, Dag S, Hlubek F, Kirchner T. beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am J Pathol. 1999;155:1033–8.PubMedCentralCrossRefPubMed
30.
Fang YJ, Lu ZH, Wang F, Wu XJ, Li LR, Zhang LY, et al. Prognostic impact of ERβ and MMP7 expression on overall survival in colon cancer. Tumour Biol. 2010;31:651–8.CrossRefPubMed
31.
Adachi Y, Yamamoto H, Itoh F, Arimura Y, Nishi M, Endo T, et al. Clinicopathologic and prognostic significance of matrilysin expression at the invasive front in human colorectal cancers. Int J Cancer. 2001;95:290–4.CrossRefPubMed
32.
Umemura K, Takagi S, Shimada T, Masuda T, Shiga H, Takahashi S, et al. Prognostic and diagnostic significance of tumor budding associated with β-catenin expression in submucosal invasive colorectal carcinoma. Tohoku J Exp Med. 2013;229:53–9.
33.
Buhmeida A, Elzagheid A, Algars A, Collan Y, Syrjänen K, Pyrhönen S. Expression of the cell-cell adhesion molecule b-catenin in colorectal carcinomas and their metastases. APMIS. 2008;116:1–9.CrossRefPubMed
34.
Ou YR, Liu J, Gao S, Jing GY, Cheng ZN, Dong XQ. Expression of secreted frizzled related protein 1, β-catenin and E-cadherin in colorectal carcinoma and its clinicopathological significances. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2014;43:397–405.PubMed
35.
Liotta LA, Stetler-Stevenson WG. Tumor Invasion and Metastasis: An Imbalance of Positive and Negative Regulation. Cancer Res. 1991;51 Suppl 18:5054s–5059s.
36.
Kauffman EC, Robinson VL, Stadler WM, Sokoloff MH, Rinker-Schaeffer CW. Metastasis suppression: the evolving role of metastasis suppressor genes for regulation cancer cell growth at the secondary site. J Urol. 2003;169:1122–33.CrossRefPubMed
37.
Chigita S, Sugiura T, Abe M, Kobayashi Y, Shimoda M, Onoda M, et al. CD82 inhibits canonical Wnt signalling by controlling the cellular distribution of β-catenin in carcinoma cells. Int J Oncol. 2012;41:2021–8.PubMedCentralPubMed
38.
Chairoungdua A, Smith DL, Pochard P, Hull M, Caplan MJ. Exosome release of β-catenin: a novel mechanism that antagonizes Wnt signaling. J Cell Biol. 2010;190:1079–91.PubMedCentralCrossRefPubMed
39.
Wielenga VJ, Smits R, Korinek V, Smit L, Kielman M, Fodde R, et al. Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway. Am J Pathol. 1999;154:515–23.PubMedCentralCrossRefPubMed
40.
Wei Q, Zhang F, Richardson MM, Roy NH, Rodgers W, Liu Y, et al. CD82 restrains pathological angiogenesis by altering lipid raft clustering and CD44 trafficking in endothelial cells. Circulation. 2014;130:1493–504.CrossRefPubMed
41.
Tang Y, Cheng Y, Martinka M, Ong CJ, Li G. Prognostic signifiance of KAI1/CD82 in human melanoma and its role in cell migration and invasion through the regulation of ING4. Carcinogenesis. 2014;35:86–95.CrossRefPubMed
42.
Jee BK, Park KM, Surendran S, Lee WK, Han CW, Kim YS, et al. KAI1/CD82 suppresses tumor invasion by MMP9 inactivation via TIMP1 up-regulation in the H1299 human lung carcinoma cell line. Biochem Biophys Res Commun. 2006;342:655–61.CrossRefPubMed
43.
Wang F, Reierstad S, Fishman DA. Matrilysin overexpression in MCF-7 cells enhances cellular invasiveness and pro-gelatinase activation. Cancer Lett. 2006;236:292–301.CrossRefPubMed
44.
Yu WH, Woessner Jr JF, McNeish JD, Stamenkovic I. CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling. Genes Dev. 2002;16:307–23.PubMedCentralCrossRefPubMed
Metadata
Title
Evaluation of the correlation of KAI1/CD82, CD44, MMP7 and β-catenin in the prediction of prognosis and metastasis in colorectal carcinoma
Authors
Qiong Wu
Yan Yang
Shiwu Wu
Wanyun Li
Na Zhang
Xiuqin Dong
Yurong Ou
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Diagnostic Pathology / Issue 1/2015
Electronic ISSN: 1746-1596
DOI
https://doi.org/10.1186/s13000-015-0411-0

Other articles of this Issue 1/2015

Diagnostic Pathology 1/2015 Go to the issue

Research

RETRACTED ARTICLE: Down-regulation of microRNA-26a and up-regulation of microRNA-27a contributes to aggressive progression of human osteosarcoma

Case Report

Renal carcinoid tumor with liver metastasis followed up postoperatively for 9 years

Research

RETRACTED ARTICLE: Investigations of renal function using the level of neutrophil gelatinase-associated lipocalin associated with single-dose of cisplatin during chemotherapy

Research

NRAS Q61R , BRAF V600E immunohistochemistry: a concomitant tool for mutation screening in melanomas

Research

Prognostic significance of FAM3C in esophageal squamous cell carcinoma

Research

RETRACTED ARTICLE: High doses of garlic extract significantly attenuated the ratio of serum LDL to HDL level in rat-fed with hypercholesterolemia diet